Skip to main content

Table 6 Multivariate logistic regression analysis of factors affecting tumor response rate (ZIO 50%)

From: Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins

  

Odds ratio

(95% CI)

P

After EC + DOC

    
 

Tumor stage

   
 

   T2

1.000

  
 

   T3

2.246

(0.290-17.420)

0.4388

 

Nodal status

   
 

   N-

1.000

  
 

   N+

3.651

(0.346-38.506)

0.2813

 

Subtype

   
 

   Luminal A, B

1.000

  
 

   HER2, Basal-like

2.484

(0.464-13.287)

0.2874

 

DDR score

   
 

   0, 1, 2

1.000

  
 

   3, 4

6.694

(1.088-41.182)

0.0402

  1. CI, confidence interval; DDR, DNA Damage Response; DOC, docetaxel; EC, epirubicin plus cyclophosphamide; HER, human epidermal growth factor receptor.